Sony’s Karate Kid: Legends debuted with $2.3M in previews, vying for attention against Disney’s Lilo & Stitch and Mission: Impossible – Final Reckoning. Can it capture the hearts of fans and box office success?
Iran has significantly increased its uranium stockpile enriched to near weapons-grade levels, raising alarms as global powers push for a nuclear deal. With tensions escalating, Iran's nuclear ambitions are under scrutiny.
A small wine-importing company, V.O.S. Selections, scored a surprising victory against Trump's tariffs in a federal court ruling. Founder Victor Schwartz shares his story of courage and the potential impact on small businesses nationwide.
In a grim update, the Palestinian Ministry of Health reports 60 deaths and 284 injuries in just 24 hours as the conflict intensifies. Meanwhile, Hamas responds to a US ceasefire proposal with conditions that remain unmet.
The stock market's turbulent start to 2025 has left Wall Street experts puzzled. Despite a strong May, the S&P 500 struggles, facing its worst year start since the 1950s. Discover what this means for investors.
A confidential IAEA report uncovers Iran's undeclared nuclear activities, raising tensions with Western nations and complicating ongoing nuclear talks. Will the world act to stop Iran's nuclear ambitions?
In a surprising decision, OPEC+ has agreed to increase oil production for the third consecutive month, despite Russia's concerns. This move could drastically reshape the global oil market.
The EU has condemned President Trump's decision to double tariffs on steel imports, warning it could worsen trade tensions and hurt consumers. With countermeasures on the table, the stakes are rising in this ongoing trade war.
In a dramatic weigh-in ahead of UFC on ESPN 68, Erin Blanchfield made weight while Maycee Barber fell short, leading to a purse penalty. Can Barber overcome the odds in her comeback fight?
President Trump faces backlash for pardoning drug dealers while advocating for harsher penalties. The release of Larry Hoover sparks debate over the effectiveness of U.S. drug policy.
